Shorts

TMS for Postpartum Depression

Antidepressants in 3rd Trimester Pregnancy

Improving Sleep Behaviors for Youth ADHD

The Myth of Monodiagnosis & Prescribing Off-Label

A New Era for Alzheimer Agitation Treatment With Auvelity

Synaptic Regrowth: A Breakthrough for Schizophrenia

GLP-1s & Plasticity: How Insulin Affects the Brain

Morning Coffee and Updates: The Executive Order on Psychedelics

New Monoclonal Antibodies: Remternetug for Alzheimer Disease

Risks of Untreated Mental Illness During Pregnancy

Donanemab Shows Robust Amyloid Lowering in Alzheimer Disease

Developing Precision Medicine for Alzheimer Disease

The #1 Tool for Managing Bipolar Disorder: Routine

Coach and Athlete Sleep: Psychiatric Perspectives

Correlation of Depression and Inflammatory Skin Disease

Pediatric Sleep Needs and Healthy Behaviors

Deprescribing and Assessing Pharmacology Over Time

Developments in Psychedelics for Depression

Forging a New Path for Treatment-Resistant Depression

AI-Related Job Loss and Psychiatric Impacts

A Turning Point in Psychedelics

Dangers of Fentanyl: Addiction and Overdose

Patient Connection: The Skill of Listening

A 3-Pronged Approach to ADHD Diagnosis

Depression and Ketamine: Increased Neuroplasticity

Interpersonal Therapy Effective for Perinatal Depression

Interactions of GLP-1s and Eating Disorders

Decriminalization vs Legalization: Psychedelic Policy Roadmap

SAMSHA Funding Reinstated by Congress: A Clinician's Perspective

Treating Athlete Pain, Pressure & Drugs